Cytarabine dose for acute myeloid leukemia.

B. Löwenberg; T. Pabst; E. Vellenga; W. van Putten; H.C. Schouten; C. Graux; A. Ferrant; P. Sonneveld; B.J. Biemond; A. Gratwohl; G.E. de Greef; L.F. Verdonck; M.R. Schaafsma; M. Gregor; M. Theobald; U. Schanz; J. Maertens; J.H.E. Kuball; x HOVON Dutch-Belgian Hematology-Oncology Group; x Swiss Group for Clinical Cancer Research Colloborative Group; G.J. Ossenkoppele

Cytarabine dose for acute myeloid leukemia.

B. Löwenberg, T. Pabst, E. Vellenga, W. van Putten, H.C. Schouten, C. Graux, A. Ferrant, P. Sonneveld, B.J. Biemond, A. Gratwohl, G.E. de Greef, L.F. Verdonck, M.R. Schaafsma, M. Gregor, M. Theobald, U. Schanz, J. Maertens, J.H.E. Kuball, x HOVON Dutch-Belgian Hematology-Oncology Group, x Swiss Group for Clinical Cancer Research Colloborative GroupG.J. Ossenkoppele

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1027-1036
Number of pages	10
Journal	New England Journal of Medicine
Volume	364
Issue number	11
Publication status	Published - 2011

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/21410371

Cite this

Löwenberg, B., Pabst, T., Vellenga, E., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Biemond, B. J., Gratwohl, A., de Greef, G. E., Verdonck, L. F., Schaafsma, M. R., Gregor, M., Theobald, M., Schanz, U., Maertens, J., Kuball, J. H. E., HOVON Dutch-Belgian Hematology-Oncology Group, X., ... Ossenkoppele, G. J. (2011). Cytarabine dose for acute myeloid leukemia. New England Journal of Medicine, 364(11), 1027-1036. http://www.ncbi.nlm.nih.gov/pubmed/21410371

@article{2d0f142f394640e99d35b659e37cc5ac,

title = "Cytarabine dose for acute myeloid leukemia.",

author = "B. L{\"o}wenberg and T. Pabst and E. Vellenga and {van Putten}, W. and H.C. Schouten and C. Graux and A. Ferrant and P. Sonneveld and B.J. Biemond and A. Gratwohl and {de Greef}, G.E. and L.F. Verdonck and M.R. Schaafsma and M. Gregor and M. Theobald and U. Schanz and J. Maertens and J.H.E. Kuball and {HOVON Dutch-Belgian Hematology-Oncology Group}, x and {Swiss Group for Clinical Cancer Research Colloborative Group}, x and G.J. Ossenkoppele",

year = "2011",

language = "English",

volume = "364",

pages = "1027--1036",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "11",

}

Löwenberg, B, Pabst, T, Vellenga, E, van Putten, W, Schouten, HC, Graux, C, Ferrant, A, Sonneveld, P, Biemond, BJ, Gratwohl, A, de Greef, GE, Verdonck, LF, Schaafsma, MR, Gregor, M, Theobald, M, Schanz, U, Maertens, J, Kuball, JHE, HOVON Dutch-Belgian Hematology-Oncology Group, X, Swiss Group for Clinical Cancer Research Colloborative Group, X & Ossenkoppele, GJ 2011, 'Cytarabine dose for acute myeloid leukemia.', New England Journal of Medicine, vol. 364, no. 11, pp. 1027-1036. <http://www.ncbi.nlm.nih.gov/pubmed/21410371>

TY - JOUR

T1 - Cytarabine dose for acute myeloid leukemia.

AU - Löwenberg, B.

AU - Pabst, T.

AU - Vellenga, E.

AU - van Putten, W.

AU - Schouten, H.C.

AU - Graux, C.

AU - Ferrant, A.

AU - Sonneveld, P.

AU - Biemond, B.J.

AU - Gratwohl, A.

AU - de Greef, G.E.

AU - Verdonck, L.F.

AU - Schaafsma, M.R.

AU - Gregor, M.

AU - Theobald, M.

AU - Schanz, U.

AU - Maertens, J.

AU - Kuball, J.H.E.

AU - HOVON Dutch-Belgian Hematology-Oncology Group, x

AU - Swiss Group for Clinical Cancer Research Colloborative Group, x

AU - Ossenkoppele, G.J.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0028-4793

VL - 364

SP - 1027

EP - 1036

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 11

ER -